Navigation Links
Targeting sugar on blood vessels may inhibit cancer growth

In a study that could point to novel therapies to prevent cancer spread, or metastasis, researchers at the University of California, San Diego (UCSD) School of Medicine have targeted a sugar that supports blood vessel growth in the tumor. Their findings will be published in the May 7 on-line issue of Journal of Cell Biology.

Lung cancer is the most common cause of cancer death and an area where novel therapies to block metastasis are desperately needed, according to first author Mark M. Fuster, M.D., assistant professor in the Division of Pulmonary and Critical Care Medicine in UCSD’s Department of Medicine. Solid tumors need a network of blood vessels, or vasculature, in order to grow, and this vasculature drives metastasis. The research team, led by the paper’s principal investigator Jeffrey D. Esko, Ph.D., professor of Cellular and Molecular Medicine at UCSD, showed that modifying the action of heparan sulfate uniquely impacted the tumor vasculature, and in doing so, altered the growth rate of tumors prepared from lung carcinoma cells in the mice.

"We theorized that by targeting the sugar, heparan sulfate, we could affect angiogenesis, which is the formation of new blood vessels," said Fuster. "In cancer, angiogenesis sustains growth as well as metastasis of tumors. An important finding was that, not only could we inhibit the growth of tumors in these mice, but that other systems that rely on endothelial growth, such as the reproductive system and wound healing, remained robust."

Studying mouse models with a genetic alteration in an important sugar-modifying enzyme (Ndst1), the researchers saw a marked decrease in the growth of experimental carcinomas. The Ndst1 enzyme is responsible for modifying the molecular structure of a sugar called heparan sulfate. In endothelial cells, this sugar facilitates the action of several important vascular growth factors that support angiogenesis.

An antibody drug called Avastin, prod
'"/>

Source:University of California - San Diego


Page: 1 2

Related biology news :

1. Targeting a key enzyme with gene therapy reversed course of Alzheimers disease in mouse models
2. Best of both worlds -- Targeting a single gene could inhibit bone decay and stimulate bone growth
3. Targeting tumors the natural way
4. Thai spice helps cut blood sugar swings
5. Cats indifference towards sugar explained
6. Life-extending protein keeps blood sugar in check
7. Too much sugar not good for coral reefs
8. Darkness unveils vital metabolic fuel switch between sugar and fat
9. Scientists seek to unwrap the sweet mystery of the sugar coat on bacteria
10. A single sugar found responsible for an antibodys ability to treat inflammation
11. Researchers attack tumor cells by exploiting dependency on sugar metabolism

Post Your Comments:
(Date:11/23/2009)...3, 2009 - The time of day matters to forest trees ...duced by a research team led by Professor Malcolm ...-principal for research and colleagues in the depa...ge campus. , Capitalizing on their previous wo...search team examined how poplar trees use their 45...
(Date:11/23/2009)...nt research suggests that a common oral bacterium ...port by Nichols et al, "Unique Lipids from a Commo...gands Capable of Enhancing Autoimmunity," appears ...l of Pathology . , Multiple sclerosis (MS), a di...d spinal cord, affects nearly 1 in 700 people in t...
(Date:11/23/2009)...y producing some of the highest resolution images ...sts have a deeper understanding how biomolecules m...ead to a new treatment for kidney stones using bio...Nov. 23 online edition of the journal Proceedings...w peptides interact with mineral surfaces by accel...
Breaking Biology News(10 mins):Time of day matters to thirsty trees, U of T researcher discovers 2Factors from common human bacteria may trigger multiple sclerosis 2Scientists watch as peptides control crystal growth with 'switches, throttles and brakes' 2Scientists watch as peptides control crystal growth with 'switches, throttles and brakes' 3New Economic Study Exposes Faults in Controversial Medicare Competitive Bidding Program Scheduled to Start this Fall 54112 1New Economic Study Exposes Faults in Controversial Medicare Competitive Bidding Program Scheduled to Start this Fall 54112 2New Economic Study Exposes Faults in Controversial Medicare Competitive Bidding Program Scheduled to Start this Fall 54112 3New Economic Study Exposes Faults in Controversial Medicare Competitive Bidding Program Scheduled to Start this Fall 54112 4FoodBizDaily com Announces New Free Report International Trade Opportunity 3A The Brazilian Acai Berry 54107 1FoodBizDaily com Announces New Free Report International Trade Opportunity 3A The Brazilian Acai Berry 54107 2Imagenetix Inc Reports First Quarter 2010 Results 13476 1Imagenetix Inc Reports First Quarter 2010 Results 13476 2Imagenetix Inc Reports First Quarter 2010 Results 13476 3Imagenetix Inc Reports First Quarter 2010 Results 13476 4Imagenetix Inc Reports First Quarter 2010 Results 13476 5
...ldlife researchers are being warned that radio-tra...ying. According to new research published today in...ed Ecology, fitting radio-collars to water voles w...atio of the animals, offspring, casting doubt on t...ntally affect the biology of radio-collared water ...
...imal geneticist Harvey D. Blackburn is responsible...f animal germplasm -- mainly semen and embryos -- ...introduce a species if necessary. Much of his coll...tein cattle and Yorkshire pigs. , But one of the c...e animal section at ARS,s National Center for Gene...
...ague, a bacterium that ravaged Europe in the Middl...al agents of bio-terrorism, may have met its match...dicine scientists. , Steven B. Mizel, Ph.D., princ...ogical Association meeting in Chicago that when mi...hallenged with a lethal dose of Yersinia pestis, t...
Other Biology News:Radio-tracking associated with 'dramatic shift' in water vole sex ratio 2Making Sure Sacred Sheep Don't Become Extinct 2Wake Forest scientists find new combination vaccine effective against plague 2
(Date:11/25/2009)..., MARKHAM, ON, Nov. 25 /PRNewswire/ - Cytochroma ...D to its Board of Directors. Dr. Moldt will replac...n the Company,s Board. The number of Board members...ery pleased to welcome Peter Moldt to the board an...nd guidance as Cytochroma continues to make progre...
(Date:11/25/2009)..., SAN DIEGO, Nov. 25 A...today that Barry D. Quart, Pharm.D., president and...r Jaffray 21st Annual Health Care Conference. , ,...y 21st Annual Health Care Conference,Date: Tu...rn Time,Location: The New York Palace Hotel, New ...
(Date:11/24/2009)... Ambassador to also Visit Detroit ...09 -- , , ,Who: David Appia, French Ambassador for... the Invest in France Agency, , , , ,What: Ambass...uss recent pro-business initiatives adopted by Fra...cademic landscape for innovation and development.,...
(Date:11/24/2009)..., CALGARY and BLENHEIM, Ontario, Nov. 24 /PRNewsw...d today it is acquiring the assets of Hyland Seeds...ario. The addition of Hyland Seeds will further ex...he company anticipates the introduction of SmartS...e Tolerant Trait Technology in corn in 2012. The t...
Breaking Biology Technology:Cytochroma Announces Appointment of Peter Moldt to Board of Directors 2Ardea Biosciences to Present at the Piper Jaffray 21st Annual Health Care Conference 2Dow AgroSciences Canada Announces Agreement to Acquire Hyland Seeds 2Dow AgroSciences Canada Announces Agreement to Acquire Hyland Seeds 3
...n Association for Cancer Research ...ADVENTRX Pharmaceuticals,Inc. (Amex: ANX ) announ...s,registrational bioequivalence clinical study of ...n Association for Cancer Research (AACR),Annual Me...kinetic,equivalence observed between an emulsion f...
...pany Kiadis,Pharma announced today that the U.S. F...product Rhitol(TM) Orphan Drug Designation for the...vHD). This complication of allogeneic,bone marrow ...ecome life,threatening when the patient is unrespo...ed a multicenter phase I/II study for patients wit...
...nsylvania, April 15, THIS ANNOUNCEMENT IS AN ADVER... NOT SUBSCRIBE FOR OR PURCHASE ANY,SECURITIES REFE...F,INFORMATION TO BE CONTAINED IN THE PROSPECTUS EX...ION WITH THE PROPOSED SCHEME. THE PROSPECTUS WILL,... AND WILL BE AVAILABLE,FOR INSPECTION AT THE UK LI...
Other Biology Technology:ANX-530 Demonstrates Equivalent Pharmacokinetics to Navelbine(R) in a Registrational Bioequivalence Clinical Study 2ANX-530 Demonstrates Equivalent Pharmacokinetics to Navelbine(R) in a Registrational Bioequivalence Clinical Study 3ANX-530 Demonstrates Equivalent Pharmacokinetics to Navelbine(R) in a Registrational Bioequivalence Clinical Study 4ANX-530 Demonstrates Equivalent Pharmacokinetics to Navelbine(R) in a Registrational Bioequivalence Clinical Study 5Kiadis Pharma Receives Orphan Drug Designation for Rhitol(TM) From the FDA 2Shire to Introduce a New UK Listed Holding Company 2Shire to Introduce a New UK Listed Holding Company 3Shire to Introduce a New UK Listed Holding Company 4Shire to Introduce a New UK Listed Holding Company 5Shire to Introduce a New UK Listed Holding Company 6Shire to Introduce a New UK Listed Holding Company 7
Agilent MSD Security ChemStation for GC and GC/MS from Agilent Technologies
File Holder from Terra Universal, Inc.
...pression profiling and built on the flexible and p...tform. These microarrays are available as part of ...rvice. Probe Content The Soil Nematode microRNA...RNAs (114 unique mature sequences). The comprehens...
...enance of appropriate levels of short-lived and re...e involved in cellular metabolism, heat shock and ...of cell surface receptors and ion channels, cell c...tors. The ubiquitin-proteasome pathway deconstruct...
Biology Products: